Cancer cells are highly dependent on methionine metabolism and several studies report AHCY as a possible therapeutic target, so global protein b-hydroxybutyrylation could play a significant role in the metabolic adaptation of cancer (77, 78). This evidence concerns the gene AHCY and cancer.